Cocrystal Pharma (COCP) SEC Filings & 10K Form → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free COCP Stock Alerts $1.56 +0.04 (+2.64%) (As of 04/26/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Recent Cocrystal Pharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/17/20244:00 PMCocrystal Pharma (Filer)Form 10-K/A03/28/20247:00 AMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/28/20247:01 AMCocrystal Pharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/19/20247:30 AMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/08/20247:00 AMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/04/20243:01 PMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/02/20248:53 AMCocrystal Pharma (Subject)SABBY MANAGEMENT, LLC (Filed by)Form SC 13G/A12/21/20234:00 PMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/06/20237:00 AMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/04/20237:00 AMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/29/20237:00 AMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/13/20237:15 AMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/13/20237:01 AMCocrystal Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 10/31/20237:00 AMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/14/20237:00 AMCocrystal Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/29/202311:15 PMCocrystal Pharma (Filer)Form EFFECT05/24/20233:31 PMCocrystal Pharma (Filer)Form S-3/A05/15/20237:00 AMCocrystal Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/15/20237:00 AMCocrystal Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: TLPH 10Q Form KPRX 10Q Form AYTU 10Q Form NRBO 10Q Form VBIV 10Q Form EDSA 10Q Form ABVC 10Q Form NERV 10Q Form BNTC 10Q Form TRAW 10Q Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:COCP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cocrystal Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
